NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Mission Bay Capital

Mission Bay Capital

San Francisco, Californiamissionbaycapital.com

Overview

Mission Bay Capital is an independent venture firm focused on making pivotal, early-stage investments in bioscience companies emerging from the University of California. Mission Bay Capital is fueling breakthrough bioscience technologies to meet society's challenges while also helping to boost the California economy. The firm is dedicated to helping entrepreneurial scientists create successful companies and provides early-stage funding necessary to prove out the technology.

Year Founded

2009

Portfolio Companies

24

Investments

Mission Bay Capital investments
CompanyDateStageLead
QurAlisMar 2023Series BCo-investor
Nitrase TherapeuticsNov 2021Series ACo-investor
Asher BiotherapeuticsSep 2021Series BCo-investor
Alpine BioJul 2021Series BCo-investor
Alpine Biomedicals Pvt Ltd.Jul 2021Series BCo-investor

Key People

Robert Blazej

Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSan Francisco, California
Year Founded2009

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.